97 related articles for article (PubMed ID: 11006967)
21. 8-OH-DPAT influences extracellular levels of serotonin and dopamine in the medial preoptic area of male rats.
Lorrain DS; Matuszewich L; Hull EM
Brain Res; 1998 Apr; 790(1-2):217-23. PubMed ID: 9593901
[TBL] [Abstract][Full Text] [Related]
22. Serotonin autoreceptor function and antidepressant drug action.
Hjorth S; Bengtsson HJ; Kullberg A; Carlzon D; Peilot H; Auerbach SB
J Psychopharmacol; 2000 Jun; 14(2):177-85. PubMed ID: 10890313
[TBL] [Abstract][Full Text] [Related]
23. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM
Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846
[TBL] [Abstract][Full Text] [Related]
24. Presynaptic modulation of synaptic gamma-aminobutyric acid transmission by tandospirone in rat basolateral amygdala.
Kishimoto K; Koyama S; Akaike N
Eur J Pharmacol; 2000 Nov; 407(3):257-65. PubMed ID: 11068021
[TBL] [Abstract][Full Text] [Related]
25. Ligands for the investigation of 5-HT autoreceptor function.
Roberts C; Price GW; Middlemiss DN
Brain Res Bull; 2001 Nov; 56(5):463-9. PubMed ID: 11750791
[TBL] [Abstract][Full Text] [Related]
26. R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex.
Kuroki T; Ichikawa J; Dai J; Meltzer HY
Brain Res; 1996 Dec; 743(1-2):357-61. PubMed ID: 9017269
[TBL] [Abstract][Full Text] [Related]
27. Serotonergic modulation of retinal input to the mouse suprachiasmatic nucleus mediated by 5-HT1B and 5-HT7 receptors.
Smith BN; Sollars PJ; Dudek FE; Pickard GE
J Biol Rhythms; 2001 Feb; 16(1):25-38. PubMed ID: 11220775
[TBL] [Abstract][Full Text] [Related]
28. The role of 5-HT1A/B autoreceptors in the antinociceptive effect of systemic administration of acetaminophen.
Roca-Vinardell A; Ortega-Alvaro A; Gibert-Rahola J; Micó JA
Anesthesiology; 2003 Mar; 98(3):741-7. PubMed ID: 12606921
[TBL] [Abstract][Full Text] [Related]
29. The 5-HT1A receptor antagonist p-MPPI blocks responses mediated by postsynaptic and presynaptic 5-HT1A receptors.
Allen AR; Singh A; Zhuang ZP; Kung MP; Kung HF; Lucki I
Pharmacol Biochem Behav; 1997; 57(1-2):301-7. PubMed ID: 9164586
[TBL] [Abstract][Full Text] [Related]
30. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
[TBL] [Abstract][Full Text] [Related]
31. Raphé grafts and 3,4-diaminopyridine-evoked overflow of serotonin in the rat hippocampus after 5,7-dihydroxytryptamine lesions: evidence for 5-HT1A autoreceptors.
Schweizer T; Birthelmer A; Jeltsch H; Cassel JC; Jackisch R
Neuroreport; 2002 Oct; 13(15):1871-4. PubMed ID: 12395082
[TBL] [Abstract][Full Text] [Related]
32. Single-dose 8-OH-DPAT pretreatment does not induce tachyphylaxis to the 5-HT release-reducing effect of 5-HT1A autoreceptor agonists.
Hjorth S
Eur J Pharmacol; 1991 Jun; 199(2):237-42. PubMed ID: 1835441
[TBL] [Abstract][Full Text] [Related]
33. Chronic administration of the 5-HT1A receptor agonist 8-OH-DPAT differentially desensitizes 5-HT1A autoreceptors of the dorsal and median raphe nuclei.
Kreiss DS; Lucki I
Synapse; 1997 Feb; 25(2):107-16. PubMed ID: 9021891
[TBL] [Abstract][Full Text] [Related]
34. Desensitization of 5-HT(1A) autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635.
Hervás I; Vilaró MT; Romero L; Scorza MC; Mengod G; Artigas F
Neuropsychopharmacology; 2001 Jan; 24(1):11-20. PubMed ID: 11106871
[TBL] [Abstract][Full Text] [Related]
35. Effects of serotonergic 5-HT1A and 5-HT1B ligands on ventral pallidal neuronal activity.
Heidenreich BA; Napier TC
Neuroreport; 2000 Sep; 11(13):2849-53. PubMed ID: 11006953
[TBL] [Abstract][Full Text] [Related]
36. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
Hjorth S; Pettersson G
Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622
[TBL] [Abstract][Full Text] [Related]
37. Deep brain stimulation and fluoxetine exert different long-term changes in the serotonergic system.
Volle J; Bregman T; Scott B; Diwan M; Raymond R; Fletcher PJ; Nobrega JN; Hamani C
Neuropharmacology; 2018 Jun; 135():63-72. PubMed ID: 29505786
[TBL] [Abstract][Full Text] [Related]
38. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
[TBL] [Abstract][Full Text] [Related]
39. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
Assié MB; Koek W
Eur J Pharmacol; 2000 Dec; 409(2):173-7. PubMed ID: 11104831
[TBL] [Abstract][Full Text] [Related]
40. Interaction of serotonin autoreceptor antagonists in the rat dorsal raphe nucleus: an in vitro fast cyclic voltammetry study.
Roberts C; Price GW
Neurosci Lett; 2001 Mar; 300(1):45-8. PubMed ID: 11172936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
